Back to search
FDAFDA · Food and drugs·Recall number D-1364-2019

Guaifenesin DAC Oral Solution, Sugar free, (Guaifenesin, Pseudoephedrine HCl and Codeine Phosphate Oral Solution, USP), Expectorant, Nasal Decongestant, Cough Suppressant, 100 mg/30 mg/10 mg per 5 mL, One Pint (473 mL) bottle, NDC: 16571-301-16, Manufactured by Bio-Pharm Inc., Levittown, PA 19057, Distributed by Rising Pharmaceuticals Inc., Allendale, NJ 07401.

Published June 19, 2019 · Recall initiated: May 21, 2019

Summary

FDA records drug Class II recall D-1364-2019, published June 19, 2019 and initiated May 21, 2019. Recalling firm: Torrent Pharma Inc; Status: Terminated; Reported quantity: 6,000 bottles; Lot: Lot #s: 17E031, Exp. 05/2019; 18F030, Exp. 06/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Torrent Pharma Inc
Distributor
Product was distributed to 9 distributors, direct accounts and relabelers who may have further distributed the product throughout the United States.
Lot
Lot #s: 17E031, Exp. 05/2019; 18F030, Exp. 06/2020.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Guaifenesin DAC Oral Solution, Sugar free, (Guaifenesin, Pseudoephedrine HCl and Codeine Phosphate Oral Solution, USP), Expectorant, Nasal Decongestant, Cough Suppressant, 100 mg/30 mg/10 mg per 5 mL, One Pint (473 mL) bottle, NDC: 16571-301-16, Manufactured by Bio-Pharm Inc., Levittown, PA 19057, Distributed by Rising Pharmaceuticals Inc., Allendale, NJ 07401. recalled?

Yes. FDA published recall D-1364-2019 on June 19, 2019. Reported hazard: cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

What should I do if I have this product?

Voluntary: Firm initiated · Letter